Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (cgp 69846a) after intravenous and subcutaneous administration-Reference-Cited by-同舟云学术

Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (cgp 69846a) after intravenous and subcutaneous administration

Published:1997-09 Issue:6 Volume:54 Page:657-668
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Phillips J.A,Craig S.J,Bayley D,Christian R.A,Geary R,Nicklin P.L

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference29 articles.

1. Inhibition of Rouse sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide;Zamecnik,1978

2. Specific regulation of gene expression by antisense, sense and antigene nucleic acids;Helene;Biochim Biophys Acta,1990

3. Therapeutic applications of oligonucleotides;Crooke,1995

4. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression;Higgins,1993

5. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against c-raf kinase;Monia;Nat Med,1996

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemistry, structure and function of approved oligonucleotide therapeutics;Nucleic Acids Research;2023-03-07

2. Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug Development;Molecules;2022-01-15

3. Recent advances in therapeutic nucleic acids and their analytical methods;Journal of Pharmaceutical and Biomedical Analysis;2021-11

4. Advances of Antisense Oligonucleotide Technology in the Treatment of Hereditary Neurodegenerative Diseases;Evidence-Based Complementary and Alternative Medicine;2021-06-10

5. Pharmacokinetics and Proceedings in Clinical Application of Nucleic Acid Therapeutics;Molecular Therapy;2021-02